MFG
ELDN icon

Merit Financial Group’s Eledon Pharmaceuticals ELDN Stock Holding History

Merit Financial Group’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.9K Buy
+11,132
New +$40.5K ﹤0.01% 2294

Other funds holding ELDN

TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
RZH
Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return
RWP
Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
SRPTWM
Split Rock Private Trading & Wealth Management Cloquet, Minnesota $146M AUM
FMII
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Merit Financial Group's ELDN Position: Q2 2026 in Review

Merit Financial Group opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 11,132 shares worth $43.9K. The stake represents ﹤0.01% of the portfolio and ranks #2294 among its holdings.

21 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Merit Financial Group held 11,132 shares of Eledon Pharmaceuticals worth $43.9K as of Q2 2026.
  • Eledon Pharmaceuticals was a new Merit Financial Group position in Q2 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2294 holding.
  • 21 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.